跳至主要内容
临床试验/IRCT2013052111421N2
IRCT2013052111421N2已完成1 期

Assessment the effect of Vitamin D supplementation on insulin resistance and Adiponectin levels in patients with Diabetes Mellitus type 2

Endocrinology and Metabolism Research Institute of Tehran University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
31 years 至 65 years(—)
性别
All

入选标准

  • Inclusion Criteria:
  • - personal tendency to take part in the study
  • - DM II which has been diagnosed at least one year ago or before
  • - The onset of diabetes should be at age 30 or older.
  • - BMI between 25 to 30 Kg/ M2
  • - Age: 31 to 65 years old
  • - 25(OH) VitD serum levels between 10-30 ng/ml
  • - Hb A1c < 8%
  • - no history of smoking
  • - no history of alcohol
  • - no history of treatment with insulin
  • - no monopose/ no pregnancy
  • - no history of using agents interacting vit D like: corticosteroids, anti-epileptics and OCP in last 6 month
  • - no history of using supplementary calcium and VitD in last 6 month
  • - no history of angina pectoris, MI & CVA in last 12 months
  • - no history of liver and kidney disease, chronic inflammatory diseases or thyroid diseases.
  • - no history of treatment with thiasolidindions
  • -failing to use prescribed supplemetary agent on the regular program
  • -any change in diet during the study
  • -any change in dose and type of prescribed medication during study
  • -lack of tendency to complete the study
  • -any history of sckeletal pain and fracture

排除标准

  • 未提供

研究者

发起方
Endocrinology and Metabolism Research Institute of Tehran University of Medical Sciences

相似试验